Antithrombotic agents: Implications in dentistry
| Autor: | Craig S. Miller, James W. Little, Bruce A McIntosh, Robert G. Henry |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
Ticlopidine medicine.drug_class Embolism Low molecular weight heparin Platelet Glycoprotein GPIIb-IIIa Complex Hemorrhagic disorder Fibrinolytic Agents Antithrombotic Humans Medicine Drug Interactions Dental Care Intensive care medicine General Dentistry Venous Thrombosis Hemostasis Aspirin Heparin business.industry Anticoagulant Warfarin Anticoagulants Thrombosis Heparin Low-Molecular-Weight medicine.disease Clopidogrel Oral Hemorrhage stomatognathic diseases Tirofiban Otorhinolaryngology Anesthesia Tyrosine Surgery Blood Coagulation Tests Oral Surgery business Platelet Aggregation Inhibitors medicine.drug |
| Zdroj: | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 93:544-551 |
| ISSN: | 1079-2104 |
| Popis: | Thrombosis and the complicating emboli that can result are important causes of illness and death. Thrombosis is of greater overall clinical importance in terms of morbidity and mortality than all of the hemorrhagic disorders combined. Agents such as heparin, low-molecular weight heparin, warfarin, aspirin, ticlopidine, clopidogrel, and tirofiban are used to prevent venous or arterial thrombosis. Patients taking these antithrombotic agents may be at risk for excessive bleeding after invasive dental procedures. The current antithrombotic agents used in medicine are reviewed, and the dental management of patients taking these agents is discussed. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:544-51) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect